SightfileU.S. market data from official filings

BioCardia Inc (BCDA)

Name: BioCardia Inc (BCDA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000925741 · EDGAR filings · Updated 2026-07-20

BioCardia Inc (BCDA) has reported institutional ownership of 6.3%, with 18 institutional managers holding positions valued at $831.1K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

6.3%

Institutional managers

Reported 13F value

$831.1K

Insider activity

43 trans.

$1.88M net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-20 — Insider transaction reported (Form 4)
2026-07-15 — Insider transaction reported (Form 4)
2026-07-10 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-07 — Insider transaction reported (Form 4)
2026-07-07 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BioCardia Inc has 18 institutional holders and institutional ownership of 6.3%.

Insider activity

Insiders reported 43 transactions (37 buys, 0 sells) across 7 reporting insiders, with a net reported value of $1.88M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-12 (recurring since 2020-04-21) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2020-04-09) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Citius Pharmaceuticals Inc (CTXR) · BULLFROG AI HLDGS INC (BFRG) · Tempest Therapeutics Inc (TPST) · INTENSITY THERAPEUTICS INC (INTS) · Phio Pharmaceuticals Corp (PHIO) · CELLECTAR BIOSCIENCES INC (CLRB)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.